These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31191182)

  • 1. Nanoparticle-Based Paramagnetic Contrast Agents for Magnetic Resonance Imaging.
    Pellico J; Ellis CM; Davis JJ
    Contrast Media Mol Imaging; 2019; 2019():1845637. PubMed ID: 31191182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents.
    Estelrich J; Sánchez-Martín MJ; Busquets MA
    Int J Nanomedicine; 2015; 10():1727-41. PubMed ID: 25834422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
    Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Advances in Lanthanide Based Nano-Architectures as Probes for Ultra High-Field Magnetic Resonance Imaging.
    Biju S; Parac-Vogt TN
    Curr Med Chem; 2020; 27(3):352-361. PubMed ID: 29421997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging.
    Siddiqui TS; Jani A; Williams F; Muller RN; Vander Elst L; Laurent S; Yao F; Wadghiri YZ; Walters MA
    J Colloid Interface Sci; 2009 Sep; 337(1):88-96. PubMed ID: 19527906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast agents for MRI.
    Shokrollahi H
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
    Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
    Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Magnetic Nanoparticles as T
    Geraldes CFGC
    Molecules; 2024 Mar; 29(6):. PubMed ID: 38542988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lanthanides in magnetic resonance imaging.
    Bottrill M; Kwok L; Long NJ
    Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paramagnetic liposomes as innovative contrast agents for magnetic resonance (MR) molecular imaging applications.
    Terreno E; Delli Castelli D; Cabella C; Dastrù W; Sanino A; Stancanello J; Tei L; Aime S
    Chem Biodivers; 2008 Oct; 5(10):1901-1912. PubMed ID: 18972531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Enhancement of Photoluminescence, MRI Relaxivity, and CT Contrast by Tuning the Interfacial Layer of Lanthanide Heteroepitaxial Nanoparticles.
    He S; Johnson NJJ; Nguyen Huu VA; Cory E; Huang Y; Sah RL; Jokerst JV; Almutairi A
    Nano Lett; 2017 Aug; 17(8):4873-4880. PubMed ID: 28657755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing T
    Marangoni VS; Neumann O; Henderson L; Kaffes CC; Zhang H; Zhang R; Bishnoi S; Ayala-Orozco C; Zucolotto V; Bankson JA; Nordlander P; Halas NJ
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6960-6965. PubMed ID: 28630340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lanthanide complexes for magnetic resonance and optical molecular imaging.
    Laurent S; Vander Elst L; Muller RN
    Q J Nucl Med Mol Imaging; 2009 Dec; 53(6):586-603. PubMed ID: 20016451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inorganic nanoparticle-based T1 and T1/T2 magnetic resonance contrast probes.
    Hu F; Zhao YS
    Nanoscale; 2012 Oct; 4(20):6235-43. PubMed ID: 22971876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR Relaxivities of Paramagnetic, Ultra-High Spin Heterometallic Clusters within Polyoxometalate Matrix as a Function of Solvent and Metal Ion.
    Schork N; Ibrahim M; Baksi A; Krämer S; Powell AK; Guthausen G
    Chemphyschem; 2022 Oct; 23(19):e202200215. PubMed ID: 35896954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-hydroxypyridinone (HOPO)-based high-relaxivity magnetic resonance imaging (MRI) contrast agents.
    Datta A; Raymond KN
    Acc Chem Res; 2009 Jul; 42(7):938-47. PubMed ID: 19505089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.
    Zhang W; Liu L; Chen H; Hu K; Delahunty I; Gao S; Xie J
    Theranostics; 2018; 8(9):2521-2548. PubMed ID: 29721097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI probes for sensing biologically relevant metal ions.
    Bonnet CS; Tóth E
    Future Med Chem; 2010 Mar; 2(3):367-84. PubMed ID: 21426172
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.